By Andrew Chung NEW YORK (Reuters) – A U.S. judge on Monday found a pattern of misconduct by Merck & Co including lying under oath and other unethical practices, freeing Gilead Sciences Inc from paying any damages for infringing Merck’s patents with its lucrative treatments…
Read More
Latest in Harvoni Archives - Access International Patent